ArticleJournal of internal medicine2025

Long-term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA-associated vasculitis in multicenter REVEAL cohort study.

Shogo Matsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.